Skip to content

A study to asses the efficacy of Thuvaraka rasayana in Psoriasis

A pre and post test study to assess the efficacy of thuvaraka rasayana regimen in psorisis Vulgaris

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008643
Enrollment
90
Registered
2017-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris Health Condition 2: null- PSORIASIS VULGARIS WITH PASI SCORE MORE THAN OR EQUAL TO 8

Interventions

Intervention1: Thuvaraka rasayana: Thuvaraka rasayana regimen will be done 35 days as ipd intervension Assessments will be taken before treatment, after treatment and during the time of follow ups f

Sponsors

Amrita school of ayurveda and amrita ayurveda hospital affiliated to amrita vishwavidhyapeetam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Psoriasis Area and Severity Index (PASI) score more than or equal to 8. 2. Diagnosed as stable Psoriasis vulgaris for at least 6 months. 3. Silvery scaly ,erythematous , thick itchy rashes with positive auspitz sign. 4. Positive histopathological report for psoriasis 5. with written consent

Exclusion criteria

Exclusion criteria: 1. Patients with psoriatic arthropaty. 2. Malignant conditions of skin. 3. Any other skin pathological conditions leading to Dermatology. 4.Pregnant and lactating mothers. 5.Mental condition rendering the subject unable to understand the nature, scope and possible consequences of the study. 6.Subject unlikely to comply with protocol (e.g. non-compliance, inability to return for follow-up visits, and likelihood of not completing the study)

Design outcomes

Primary

MeasureTime frame
PASITimepoint: PASI 50

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactDr James Chacko

Amrita school of Ayurveda/Amrita vishwa vidhyapeetham

drjameschacko.2008@gmail.com9495191191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026